CN116997325B - 稳定的吲哚菁绿制剂 - Google Patents
稳定的吲哚菁绿制剂Info
- Publication number
- CN116997325B CN116997325B CN202280021996.7A CN202280021996A CN116997325B CN 116997325 B CN116997325 B CN 116997325B CN 202280021996 A CN202280021996 A CN 202280021996A CN 116997325 B CN116997325 B CN 116997325B
- Authority
- CN
- China
- Prior art keywords
- indocyanine green
- composition
- weight
- icg
- edta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
- A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21305323.4 | 2021-03-17 | ||
| EP21305323 | 2021-03-17 | ||
| PCT/EP2022/056445 WO2022194733A2 (en) | 2021-03-17 | 2022-03-14 | Stable formulations of indocyanine green |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116997325A CN116997325A (zh) | 2023-11-03 |
| CN116997325B true CN116997325B (zh) | 2025-12-05 |
Family
ID=75302475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280021996.7A Active CN116997325B (zh) | 2021-03-17 | 2022-03-14 | 稳定的吲哚菁绿制剂 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240165275A1 (enExample) |
| EP (1) | EP4308081A2 (enExample) |
| JP (1) | JP7842776B2 (enExample) |
| CN (1) | CN116997325B (enExample) |
| BR (1) | BR112023018942A2 (enExample) |
| WO (1) | WO2022194733A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119215199B (zh) * | 2024-10-12 | 2025-12-09 | 石家庄四药有限公司 | 一种注射用吲哚菁绿的冻干工艺 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111514125A (zh) * | 2020-05-26 | 2020-08-11 | 中山万汉制药有限公司 | 含有喹诺酮类化合物与依地酸类化合物的组合物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08509260A (ja) * | 1993-04-20 | 1996-10-01 | マリンクロット・メディカル・インコーポレイテッド | 電圧感受性染料の安定化 |
| FR2710060B1 (fr) | 1993-09-17 | 1995-11-17 | Rech Biolog Et | Procédé de préparation de benz[e]indoles substitués de pureté élevée et leurs sels alcalins. |
| GB9712524D0 (en) | 1997-06-16 | 1997-08-20 | Nycomed Imaging As | Method |
| US6944493B2 (en) | 1999-09-10 | 2005-09-13 | Akora, Inc. | Indocyanine green (ICG) compositions and related methods of use |
| US8337809B2 (en) * | 2006-09-11 | 2012-12-25 | William Marsh Rice University | Charge-assembled capsules for phototherapy |
| DE102007030403A1 (de) | 2007-06-29 | 2009-01-08 | Universität Bielefeld | Verfahren zur Verbesserung der Photostabilität von Fluoreszenzfarbstoffen |
| JP5257971B2 (ja) | 2007-10-25 | 2013-08-07 | 国立大学法人 千葉大学 | 胚性幹細胞から肝芽細胞を得る方法 |
| CN103301482B (zh) | 2013-06-27 | 2014-12-17 | 深圳先进技术研究院 | 两亲性三嵌段聚多肽载icg胶束及其制备方法 |
| JP2015040185A (ja) | 2013-08-21 | 2015-03-02 | キヤノン株式会社 | 造影用組成物 |
| JP6623479B2 (ja) | 2015-02-08 | 2019-12-25 | トンリ・バイオメディカル・カンパニー・リミテッド | 脂質ナノ粒子及びその使用 |
| CA3021809A1 (en) | 2015-05-11 | 2016-11-17 | Dicronis Sagl | Compositions for circulatory system visualization |
| DK3383436T3 (da) | 2015-12-01 | 2023-11-20 | Dishman Carbogen Amcis Ltd | Forbedret fremgangsmåde til fremstilling af indocyaningrønt |
| US20190337896A1 (en) | 2018-05-02 | 2019-11-07 | Biophore India Pharmaceuticals Pvt. Ltd. | PROCESS FOR THE PREPARATION OF SODIUM 4-(2-((1E,3E,5E,7Z)-7-(1,1-DIMETHYL-3-(4-SULFONATOBUTYL)-1H-BENZO[e]INDOL-2(3H)-YLIDENE) HEPTA-1,3,5-TRIENYL)-1,1-DIMETHYL-1H-BENZO[e]INDOLIUM-3-YL) BUTANE-1-SULFONATE (INDOCYANINE GREEN) |
| WO2020240514A1 (en) * | 2019-05-30 | 2020-12-03 | Leiutis Pharmaceuticals Pvt, Ltd. | Stable formulations of indocyanine green |
-
2022
- 2022-03-14 US US18/549,373 patent/US20240165275A1/en active Pending
- 2022-03-14 WO PCT/EP2022/056445 patent/WO2022194733A2/en not_active Ceased
- 2022-03-14 EP EP22712419.5A patent/EP4308081A2/en active Pending
- 2022-03-14 CN CN202280021996.7A patent/CN116997325B/zh active Active
- 2022-03-14 BR BR112023018942A patent/BR112023018942A2/pt unknown
- 2022-03-14 JP JP2023557322A patent/JP7842776B2/ja active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111514125A (zh) * | 2020-05-26 | 2020-08-11 | 中山万汉制药有限公司 | 含有喹诺酮类化合物与依地酸类化合物的组合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116997325A (zh) | 2023-11-03 |
| EP4308081A2 (en) | 2024-01-24 |
| US20240165275A1 (en) | 2024-05-23 |
| JP7842776B2 (ja) | 2026-04-08 |
| WO2022194733A2 (en) | 2022-09-22 |
| BR112023018942A2 (pt) | 2023-10-10 |
| WO2022194733A3 (en) | 2022-11-10 |
| JP2024510302A (ja) | 2024-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW457095B (en) | Pharmaceutical formulations comprising epothilones and lyophilised compositions comprising epothilones | |
| KR20090052920A (ko) | 우수한 안정성을 갖는 택산 유도체 함유 주사제용동결건조 조성물 및 이의 제조방법 | |
| WO2012004438A1 (es) | Una formulación farmacéutica inyectable de melfalano | |
| WO2008023807A1 (fr) | Composition pharmaceutique stabilisée | |
| FI101597B (fi) | Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi pot ilaan valodynaamisessa hoidossa tai diagnosoinnissa | |
| JP7400180B2 (ja) | 非経口製剤及びその使用 | |
| JP7842776B2 (ja) | インドシアニングリーンの安定な処方物 | |
| EP4308076B1 (en) | Stable formulations of indocyanine green | |
| CN117062597B (zh) | 稳定的吲哚菁绿制剂 | |
| KR20100019979A (ko) | 의약조성물 | |
| JP7618235B2 (ja) | p-ボロノフェニルアラニンを含有する注射液剤の析出防止方法 | |
| WO2014204952A1 (en) | Stable bromfenac solution | |
| MXPA94002884A (es) | Composicion acuosa estable durante el almacenamiento y metodo para hacer la misma. | |
| JP3668225B2 (ja) | Oct製剤 | |
| CA2486571C (en) | Pharmaceutical composition | |
| HUP0400754A2 (hu) | Injektálható galenusi készítmény fotodinamikus diagnosztikában vagy terápiában való felhasználásra és eljárás annak előállítására | |
| TW202114717A (zh) | 含有對硼苯基丙胺酸之注射液劑 | |
| CN114144186A (zh) | 含有对硼基苯丙氨酸的药物组合物及其制造方法 | |
| HK40119827A (en) | Stable plinabulin formulations and methods of their preparation and use | |
| EP4615408A1 (en) | Vasopressin formulation | |
| JP2022155560A (ja) | スガマデクスの光分解抑制方法 | |
| CN120789252A (zh) | 一种共递送吴茱萸碱与Ppa的纳米药物及其制备方法和应用 | |
| JP2024529176A (ja) | 薬物組成物、その調製方法及び応用 | |
| CA3256560A1 (en) | LYOPHILIZED PHARMACEUTICAL COMPOSITIONS OF COPPER HISTIDINATE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |